GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Exelixis, Inc. (EXEL) [hlAlert]

Exelixis, Inc. (Exelixis) is developing therapies for cancer and other serious diseases. Through its drug discovery and development activities, the Company is building a portfolio of novel compounds. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer,
renal disease and various metabolic and cardiovascular disorders. Its most advanced pharmaceutical programs focus on drug discovery and development of small molecule drugs for cancer. The Company has nine compounds in clinical development: XL184, XL147, XL765, XL518, XL228, XL019, XL139, XL413 and XL888. Exelixis also has out-licensed to third parties for further development and commercialization of five compounds in preclinical and clinical development: XL880, XL281, XL652, XL550 and FXR Program. The Company has established commercial collaborations with several pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, Genentech, Inc. and GlaxoSmithKline.
.
( Total: 14 Current Stock Recommendations )
Exelixis, Inc.   (14)
Hold 64% Buy 36%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
7/26/2007  
Hold
  
9/4/2007  
Hold
  
12/7/2007  
Hold
  
8/6/2008  
Hold
  
8/14/2008  
Hold
  
10/16/2008  
Buy
  
12/15/2008  
Buy
  
6/17/2009  
Hold
  
11/18/2009  
Hold
  
11/30/2012  
Buy
  
1/6/2014  
Buy
  
1/21/2014  
Buy
  
1/28/2014  
Hold
  
9/2/2014  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy